BMGL
BMGL
NASDAQ · Health Care

Basel Medical Group Ltd

$3.47
-0.23 (-6.22%)
As of Sep 28, 10:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
11.41M
Net Income
-10,720,664
Gross Margin
—
Profit Margin
-94.0%
Rev Growth
+2.0%
D/E Ratio
0.93
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 38.9% 38.9%
Operating Margin -88.8% -79.9% 11.9% 13.4%
Profit Margin -94.0% -89.3% 11.7% 11.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.41M 11.18M 6.80M 6.40M
Gross Profit — — 2.64M 2.49M
Operating Income -10,130,135 -8,935,726 808.2K 856.0K
Net Income -10,720,664 -9,456,628 795.8K 756.4K
Gross Margin — — 38.9% 38.9%
Operating Margin -88.8% -79.9% 11.9% 13.4%
Profit Margin -94.0% -89.3% 11.7% 11.8%
Rev Growth +2.0% +2.0% -8.5% +14.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.44M 1.44M 4.33M 4.62M
Total Equity 1.54M 1.54M 8.88M 9.45M
D/E Ratio 0.93 0.93 0.49 0.49
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,939,488 -8,323,545 1.21M 1.15M
Free Cash Flow — — 635.1K 614.1K